Khabor Wala Desk
Published: 13th April 2026, 4:58 PM
South Korea’s Kyobo Life Insurance reported a notable rebound in net profit for the 2025 financial year, even as its core insurance business showed signs of strain. The insurer posted a net profit of $0.5 billion (KRW763.2 billion), marking a 9.2% year-on-year increase and reversing the decline observed earlier in the year.
However, the improvement was largely driven by non-operational factors rather than fundamental business strength. In particular, a sharp reduction in associate impairment losses played a decisive role in lifting overall profitability. These losses fell significantly to $0.1 billion (KRW119 billion) in 2025, compared with $0.2 billion (KRW279 billion) the previous year, providing a substantial boost to the bottom line.
Despite the rise in net profit, Kyobo Life’s core insurance performance weakened considerably. Insurance profit for the year declined by 17.3% to $0.3 billion (KRW391.6 billion), reflecting mounting cost pressures and less favourable actuarial developments.
Although service income increased by 8.4%, this gain was more than offset by a sharp rise in insurance service expenses, which climbed 11.8% to reach $2.7 billion (KRW4.0 trillion). The widening gap between income and expenses underscores the challenges facing the insurer’s core operations.
Two key factors contributed to the deterioration:
These elements highlight the sensitivity of life insurers to shifts in long-term assumptions such as mortality rates, policyholder behaviour, and discount rates.
Kyobo Life’s investment segment offered little support to overall earnings growth. Investment profit remained broadly flat at $0.5 billion (KRW670.0 billion), as increases in investment income were largely offset by rising expenses.
This stagnation reflects a challenging investment environment, where insurers must balance the need for yield generation against market volatility and regulatory constraints. With interest rates and asset valuations fluctuating, maintaining stable investment returns has become increasingly complex.
A summary of Kyobo Life’s key financial indicators is presented below:
| Metric | 2025 შედეგ | 2024 Result | Change (%) |
|---|---|---|---|
| Net Profit | $0.5b | $0.46b | +9.2% |
| Insurance Profit | $0.3b | $0.47b | -17.3% |
| Investment Profit | $0.5b | $0.5b | ~0% |
| Associate Impairment Losses | $0.1b | $0.2b | -~57% |
| Insurance Service Expenses | $2.7b | $2.4b | +11.8% |
According to CreditSights, Kyobo Life’s future performance will depend heavily on several critical factors.
First, the stability of actuarial assumptions will be closely monitored. Any further adverse revisions could exert additional pressure on insurance profitability and capital adequacy.
Second, the performance of associate subsidiaries will remain a key variable. Given the significant impact of impairment losses on recent results, fluctuations in the valuation of these investments could materially affect earnings.
Finally, regulatory developments will play an important role. In particular, the gradual withdrawal of regulatory relief measures for lapse risks—introduced to cushion insurers against policy cancellations—may create additional headwinds if not carefully managed.
While Kyobo Life’s headline profit growth presents a positive narrative, the underlying picture is more complex. The reliance on reduced impairment losses rather than stronger operational performance raises questions about the sustainability of earnings growth.
As cost pressures mount and regulatory conditions evolve, the insurer faces a delicate balancing act: strengthening its core insurance operations whilst maintaining stable investment returns. The coming years will be critical in determining whether Kyobo Life can translate short-term gains into durable, long-term profitability.
Comments